IL-6 Blockade Limitations as an Anticancer Strategy: Literature Review and Proposal of Explanations for Unexpected Results
Asian Oncology Research Journal · pp. 1–5 · Published 10 Jan 2020
Abstract
IL-6 is a cytokine with multiple protumorigenic effects, making it an interesting therapeutic target. IL-6 inhibitors with an acceptable safety profile had been developed and tested in experimental and clinical trials. However, the outcomes were not as expected theoretically. Possible explanations of this discordance had been advocated by authors and will be reviewed in this paper. Additional reasons, such as the antitumoral effects of IL-6 and overcompensation by alternative agents will be proposed. These may also explain the trending to negative results constated in some clinical trials.
Cited by 0
No indexed citations yet.
Related research
- Lipid Profile Indices and Inflammatory Biomarkers as Predictors of Subclinical Muscle Loss in Young Obese Females — shares topic coverage
- Elevated Peripheral Blood IL-6 Levels: A Novel Biomarker for Assessing Inflammation and Exacerbation Risk in Pediatric Bronchial Asthma — shares topic coverage
- Associations between TNF-α, IL-6 and IL-10 Promoter Polymorphisms and Mortality in Severe Sepsis — shares topic coverage
- Role of Serum Adiponectin, IL-6 and Hs CRP in Nonalcoholic Fatty Liver Egyptian Patients — shares topic coverage
- Therapeutic Potential of Methanolic Stem Extract of Costus afer on Serum Uric Acid, Tumor Necrosis Factor-alpha (TNF-α), and Interleukin-6 (IL-6) Levels in Monosodium Urate (MSU)-Induced Gouty Arthritis in Wistar Rats — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.